Revealing the antibacterial power of hydrogen-releasing PdH nanohydride against drug resistant Staphylococcus aureus : an in-depth mechanism study.

Currently, multidrug resistant (MDR) bacterial infections are a great threat to public health, and the development of novel strategies for high efficiency combatting of MDR bacteria is in urgent demand. Hydrogen (H) is a small gas with a high reducing ability, and plenty of recent studies have demonstrated its therapeutic effect on many diseases. However, the antibacterial effectiveness and mechanism of H against MDR bacteria are still unknown. In the present work, using PdH nanohydride with a temperature responsive H-releasing property as the H source, we demonstrated that H was not only able to inhibit the growth of normal (), but could also effectively eliminate single drug resistant () and multidrug resistant (), as well as the biofilms formed by those bacteria. Moreover, an in-depth mechanism regarding the anti-antibiotic-resistance activity of H was elucidated by us, in which H exerted its antibacterial effect by firstly causing severe membrane damage, followed by boosting generation of intracellular ROS, which subsequently triggered DNA damage and finally led to bacterial death. The proposed mechanism was further verified by genomic analysis, where a cluster of genes related to bacterial membrane integrity, biofilm formation, metabolism and DNA functions was significantly perturbed by the released H. In particular, H boosted intracellular ROS generation by destroying the redox homeostasis of bacterial metabolism. More importantly, we revealed that H was able to alleviate the antibiotic resistance of and by significantly down-regulating the expression of many drug-resistant genes, the gene of , and , , and genes of , as well as reducing the minimal inhibitory concentration (MIC) of ciprofloxacin/ampicillin against /. The findings in our work suggested that H therapy is a promising tool for combating antibiotic-resistant bacteria.